New York State Department of Health
Castle Biosciences Gains New York State Approval for Pittsburgh Laboratory
The company can now serve NY state patients from either of its two facilities, in addition to populations across other US states under its existing CLIA certifications.
New York State Department of Health Approves Smart In Media Digital Pathology Solution
The whole-slide imaging-based method for digital slide scanning can be used with fine needle aspirates specimens.
Myriad Genetics, Intermountain Precision Genomics Obtain NY Certification for Solid Tumor Testing
The NYS certification enables the companies to offer solid tumor testing through the Precise Oncology Solutions suite in all 50 states.
Sema4's GeneDx to Provide Genome Sequencing, Interpretation for Large-Scale Newborn Screening Study
The GUARDIAN (Genomic Uniform-screening Against Rare Diseases in All Newborns) study plans to screen 100,000 newborns for up to 250 rare genetic conditions.
DxTerity Gets New York State Authorization for Systemic Lupus Erythematosus Test
The test is used to identify patients less likely to respond to standard treatment and more likely to develop a severe kidney disorder.
Feb 24, 2020